-transparent.png){kind=logo}
We studied the renal vascular effects of flupenthixol and sulpiride isomers in the isolated perfused rat kidney in the presence of phenoxybenzamine (10(-5) M) and sotalol (10(-5) M). The vascular bed was contracted with prostaglandin F2 alpha (10(-7) -3 X 10(-6) M) and dose-dependently relaxed with dopamine. Cis-flupenthixol (10(-9)-10(-7) M) antagonized competitively the response to dopamine (apparent pA2 = 8.34 +/- 0.09; mean +/- SD) without affecting papaverine-induced relaxation. Trans-flupenthixol was without effect at 10(-7) M. The dopamine receptor antagonist activities of the sulpiride isomers are low and d-sulpiride is twice as active as 1-sulpiride. Thus, the renal vascular dopamine receptor can be further characterized by the relative antagonist activities of cis-flupenthixol and sulpiride and by a rather low stereospecificity in favor of d-sulpiride.
M Schmidt, and
J L Imbs, and
E M Giesen, and
J Schwartz
November 1979,
British journal of pharmacology,
M Schmidt, and
J L Imbs, and
E M Giesen, and
J Schwartz
February 1982,
European journal of pharmacology,
M Schmidt, and
J L Imbs, and
E M Giesen, and
J Schwartz
October 1977,
British journal of clinical pharmacology,
M Schmidt, and
J L Imbs, and
E M Giesen, and
J Schwartz
May 1984,
Neuropharmacology,
M Schmidt, and
J L Imbs, and
E M Giesen, and
J Schwartz
May 1991,
European journal of pharmacology,
M Schmidt, and
J L Imbs, and
E M Giesen, and
J Schwartz
January 1985,
The Journal of pharmacology and experimental therapeutics,
M Schmidt, and
J L Imbs, and
E M Giesen, and
J Schwartz
January 1989,
Psychopharmacology,
M Schmidt, and
J L Imbs, and
E M Giesen, and
J Schwartz
January 1985,
Journal of neural transmission,
M Schmidt, and
J L Imbs, and
E M Giesen, and
J Schwartz
April 1982,
Neuropharmacology,
M Schmidt, and
J L Imbs, and
E M Giesen, and
J Schwartz
January 1995,
Journal of vascular research,
